Skip to main content
Erschienen in: Inflammation 6/2019

22.08.2019 | Original Article

MMP-9 Inhibition Suppresses Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells

verfasst von: Keiko Aota, Shinji Ono, Tomoko Yamanoi, Koichi Kani, Yukihiro Momota, Masayuki Azuma

Erschienen in: Inflammation | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Gene expression profiling of lip salivary gland (LSG) has shown that C-X-C motif chemokine 10 (CXCL10) and matrix metalloproteinase 9 (MMP9) expression is upregulated in primary Sjögren’s syndrome (pSS) patients. Although CXCL10 and MMP-9 are both associated with pSS pathogenesis, the potential relationship between these two factors has not been investigated. In this study, we used LSG sections from pSS patients and human salivary gland cell lines to investigate the relationship between CXCL10 and MMP-9. Immunofluorescence analyses revealed that CXCL10 and MMP-9 were co-expressed in the LSG of pSS patients, particularly in expanded ductal cells. Furthermore, RT-qPCR analyses on human salivary gland ductal NS-SV-DC cells confirmed that CXCL10 expression was induced by interferon (IFN)-γ, whereas that of MMP9 was stimulated by IFN-α, tumor necrosis factor-α, and interleukin-1β. Remarkably, MMP-9 inhibition in IFN-γ-stimulated NS-SV-DC cells significantly decreased CXCL10 mRNA and secreted protein levels. Further analyses established that MMP-9 inhibition in IFN-γ-stimulated NS-SV-DC cells decreased STAT1 phosphorylation and hence suppressed IFN-γ signaling. Collectively, these results suggest that in addition to its reported role in the destruction of acinar structures, MMP-9 is involved in the IFN-γ-induced production of CXCL10 in pSS lesions. We believe that our findings open the door to the development of novel treatments for pSS, based on the modulation of MMP-9 activity.
Literatur
1.
Zurück zum Zitat Alspaugh, M.A., and K. Whaley. 1981. Sjögren’s syndrome. In Textbook of Rheumatology, ed. W.N. Kelley, E.D. Harris, S. Ruddy, and C.B. Sledge, 971–999. Philadelphia: Saunders (imprint). Alspaugh, M.A., and K. Whaley. 1981. Sjögren’s syndrome. In Textbook of Rheumatology, ed. W.N. Kelley, E.D. Harris, S. Ruddy, and C.B. Sledge, 971–999. Philadelphia: Saunders (imprint).
2.
Zurück zum Zitat Vivino, F.B., V.Y. Bunya, G. Massaro-Giordano, C.R. Johr, S.L. Giattino, A. Schorpion, B. Shafer, A. Peck, K. Sivils, A. Rasmussen, J.A. Chiorini, J. He, and J.L. Ambrus Jr. 2019. Sjogren’s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clinical Immunology 203: 81–121.CrossRef Vivino, F.B., V.Y. Bunya, G. Massaro-Giordano, C.R. Johr, S.L. Giattino, A. Schorpion, B. Shafer, A. Peck, K. Sivils, A. Rasmussen, J.A. Chiorini, J. He, and J.L. Ambrus Jr. 2019. Sjogren’s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clinical Immunology 203: 81–121.CrossRef
3.
Zurück zum Zitat Daniel, T.E. 1984. Labial salivary gland biopsy in Sjögren’s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis and Rheumatism 27: 147–156.CrossRef Daniel, T.E. 1984. Labial salivary gland biopsy in Sjögren’s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis and Rheumatism 27: 147–156.CrossRef
4.
Zurück zum Zitat Christodoulou, M.I., E.K. Kapsogeorgou, and H.M. Moutsopoulos. 2010. Characteristics of the minor salivary gland infiltrates in Sjögren’s syndrome. Journal of Autoimmunity 34: 400–407.CrossRef Christodoulou, M.I., E.K. Kapsogeorgou, and H.M. Moutsopoulos. 2010. Characteristics of the minor salivary gland infiltrates in Sjögren’s syndrome. Journal of Autoimmunity 34: 400–407.CrossRef
5.
Zurück zum Zitat Kamiński, B. 2019. Laryngological manifestations of Sjögren’s syndrome. Reumatologia 57: 37–44.CrossRef Kamiński, B. 2019. Laryngological manifestations of Sjögren’s syndrome. Reumatologia 57: 37–44.CrossRef
6.
Zurück zum Zitat Lee, Y.J., R.H. Scofield, J.Y. Hyon, P.Y. Yun, H.J. Lee, E.Y. Lee, E.B. Lee, and Y.W. Song. 2010. Salivary chemokine levels in patients with primary Sjögren’s syndrome. Rheumatology (Oxford) 49: 1747–1752.CrossRef Lee, Y.J., R.H. Scofield, J.Y. Hyon, P.Y. Yun, H.J. Lee, E.Y. Lee, E.B. Lee, and Y.W. Song. 2010. Salivary chemokine levels in patients with primary Sjögren’s syndrome. Rheumatology (Oxford) 49: 1747–1752.CrossRef
7.
Zurück zum Zitat Ogawa, N., L. Ping, L. Zhenjun, Y. Takada, and S. Sugai. 2002. Involvement of the interferon-γ-induced T cell-attracting chemokines, interferon-γ-inducible 10-kd protein (CXCL10) and monokine induced by interferon-γ (CXCL9), in the salivary gland lesions of patients with Sjögren’s syndrome. Arthritis and Rheumatism 46: 2730–2741.CrossRef Ogawa, N., L. Ping, L. Zhenjun, Y. Takada, and S. Sugai. 2002. Involvement of the interferon-γ-induced T cell-attracting chemokines, interferon-γ-inducible 10-kd protein (CXCL10) and monokine induced by interferon-γ (CXCL9), in the salivary gland lesions of patients with Sjögren’s syndrome. Arthritis and Rheumatism 46: 2730–2741.CrossRef
8.
Zurück zum Zitat Aota, K., K. Kani, T. Yamanoi, K.I. Nakashiro, N. Ishimaru, and M. Azuma. 2018. Distinct regulation of CXCL10 production by cytokines in human salivary gland ductal and acinar cells. Inflammation 41: 1172–1181.CrossRef Aota, K., K. Kani, T. Yamanoi, K.I. Nakashiro, N. Ishimaru, and M. Azuma. 2018. Distinct regulation of CXCL10 production by cytokines in human salivary gland ductal and acinar cells. Inflammation 41: 1172–1181.CrossRef
9.
Zurück zum Zitat Aota, K., T. Yamanoi, K. Kani, K.I. Nakashiro, N. Ishimaru, and M. Azuma. 2018. Inverse correlation between the number of CXCR3+ macrophages and the severity of inflammatory lesions in Sjögren's syndrome salivary glands: A pilot study. Journal of Oral Pathology and Medicine 47: 710–718.CrossRef Aota, K., T. Yamanoi, K. Kani, K.I. Nakashiro, N. Ishimaru, and M. Azuma. 2018. Inverse correlation between the number of CXCR3+ macrophages and the severity of inflammatory lesions in Sjögren's syndrome salivary glands: A pilot study. Journal of Oral Pathology and Medicine 47: 710–718.CrossRef
10.
Zurück zum Zitat Luster, A.D., J.C. Unkeless, and J.V. Ravetch. 1985. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315: 672–676.CrossRef Luster, A.D., J.C. Unkeless, and J.V. Ravetch. 1985. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315: 672–676.CrossRef
11.
Zurück zum Zitat García-López, M.A., F. Sánchez-Madrid, J.M. Rodríguez-Frade, M. Mellado, A. Acevedo, M.I. García, J.P. Albar, C. Martínez-A, and M. Marazuela. 2001. CXCR3 chemokine receptor distribution in normal and inflamed tissues: Expression on activated lymphocytes, endothelial cells, and dendritic cells. Laboratory Investigation 81: 409–418.CrossRef García-López, M.A., F. Sánchez-Madrid, J.M. Rodríguez-Frade, M. Mellado, A. Acevedo, M.I. García, J.P. Albar, C. Martínez-A, and M. Marazuela. 2001. CXCR3 chemokine receptor distribution in normal and inflamed tissues: Expression on activated lymphocytes, endothelial cells, and dendritic cells. Laboratory Investigation 81: 409–418.CrossRef
12.
Zurück zum Zitat Groom, J.R., and A.D. Luster. 2011. CXCR3 ligands: Redundant, collaborative and antagonistic functions. Immunology and Cell Biology 89: 207–215.CrossRef Groom, J.R., and A.D. Luster. 2011. CXCR3 ligands: Redundant, collaborative and antagonistic functions. Immunology and Cell Biology 89: 207–215.CrossRef
13.
Zurück zum Zitat Hartl, D., S. Krauss-Etschmann, B. Koller, P.L. Hordijk, T.W. Kuijpers, F. Hoffmann, A. Hector, E. Eber, V. Marcos, I. Bittmann, O. Eickelberg, M. Griese, and D. Roos. 2008. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. The Journal of Immunology 181: 8053–8067.CrossRef Hartl, D., S. Krauss-Etschmann, B. Koller, P.L. Hordijk, T.W. Kuijpers, F. Hoffmann, A. Hector, E. Eber, V. Marcos, I. Bittmann, O. Eickelberg, M. Griese, and D. Roos. 2008. Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. The Journal of Immunology 181: 8053–8067.CrossRef
14.
Zurück zum Zitat Tomita, K., B.L. Freeman, S.F. Bronk, N.K. LeBrasseur, T.A. White, P. Hirsova, and S.H. Ibrahim. 2016. CXCL10-mediates macrophage, but not other innate immune cells-associated inflammation in murine nonalcoholic steatohepatitis. Scientific Reports 6: 28786.CrossRef Tomita, K., B.L. Freeman, S.F. Bronk, N.K. LeBrasseur, T.A. White, P. Hirsova, and S.H. Ibrahim. 2016. CXCL10-mediates macrophage, but not other innate immune cells-associated inflammation in murine nonalcoholic steatohepatitis. Scientific Reports 6: 28786.CrossRef
15.
Zurück zum Zitat Hjelmervik, T.O., K. Petersen, I. Jonassen, R. Jonsson, and A.I. Bolstad. 2005. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren’s syndrome patients from healthy control subjects. Arthritis and Rheumatism 52: 1534–1544.CrossRef Hjelmervik, T.O., K. Petersen, I. Jonassen, R. Jonsson, and A.I. Bolstad. 2005. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren’s syndrome patients from healthy control subjects. Arthritis and Rheumatism 52: 1534–1544.CrossRef
16.
Zurück zum Zitat Szabo, K.A., R.J. Ablin, and G. Singh. 2004. Matrix metalloproteinases and the immune response. Clinical and Applied Immunology Reviews 4: 295–319.CrossRef Szabo, K.A., R.J. Ablin, and G. Singh. 2004. Matrix metalloproteinases and the immune response. Clinical and Applied Immunology Reviews 4: 295–319.CrossRef
17.
Zurück zum Zitat Bernfield, M.R., S.D. Banerjee, and R.H. Cohn. 1972. Dependence of salivary epithelial morphology and branching morphogenesis upon acid mucopolysaccharide-protein (proteoglycan) at the epithelial surface. Journal of Cell Biology 52: 674–689.CrossRef Bernfield, M.R., S.D. Banerjee, and R.H. Cohn. 1972. Dependence of salivary epithelial morphology and branching morphogenesis upon acid mucopolysaccharide-protein (proteoglycan) at the epithelial surface. Journal of Cell Biology 52: 674–689.CrossRef
18.
Zurück zum Zitat Patel, V.N., and M.P. Hoffman. 2014. Salivary gland development: A template for regeneration. Seminars in Cell and Developmental Biology 25-26: 52–60.CrossRef Patel, V.N., and M.P. Hoffman. 2014. Salivary gland development: A template for regeneration. Seminars in Cell and Developmental Biology 25-26: 52–60.CrossRef
19.
Zurück zum Zitat Pérez, P., J.M. Anaya, S. Aguilera, U. Urzúa, D. Munroe, C. Molina, M.A. Hermoso, J.M. Cherry, C. Alliende, N. Olea, E. Ruiz-Narváez, and M.J. González. 2009. Gene expression and chromosomal location for susceptibility to Sjögren’s syndrome. Journal of Autoimmunity 33: 99–108.CrossRef Pérez, P., J.M. Anaya, S. Aguilera, U. Urzúa, D. Munroe, C. Molina, M.A. Hermoso, J.M. Cherry, C. Alliende, N. Olea, E. Ruiz-Narváez, and M.J. González. 2009. Gene expression and chromosomal location for susceptibility to Sjögren’s syndrome. Journal of Autoimmunity 33: 99–108.CrossRef
20.
Zurück zum Zitat Konttinen, Y.T., S. Halinen, R. Hanemaaijer, T. Sorsa, J. Hietanen, A. Ceponis, J.W. Xu, R. Manthorpe, J. Whittington, A. Larsson, T. Salo, L. Kjeldsen, U.H. Stenman, and A.Z. Eisen. 1998. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren’s syndrome. Matrix Biology 17: 335–347.CrossRef Konttinen, Y.T., S. Halinen, R. Hanemaaijer, T. Sorsa, J. Hietanen, A. Ceponis, J.W. Xu, R. Manthorpe, J. Whittington, A. Larsson, T. Salo, L. Kjeldsen, U.H. Stenman, and A.Z. Eisen. 1998. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren’s syndrome. Matrix Biology 17: 335–347.CrossRef
21.
Zurück zum Zitat Azuma, M., K. Aota, T. Tamatani, K. Motegi, T. Yamashita, K. Harada, Y. Hayashi, and M. Sato. 2000. Suppression of tumor necrosis factor α-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor κBα complementary DNA into immortalized human salivary gland acinar cells: Prevention of the destruction of the acinar structure in Sjögren's syndrome salivary glands. Arthritis and Rheumatism 43: 1756–1767.CrossRef Azuma, M., K. Aota, T. Tamatani, K. Motegi, T. Yamashita, K. Harada, Y. Hayashi, and M. Sato. 2000. Suppression of tumor necrosis factor α-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor κBα complementary DNA into immortalized human salivary gland acinar cells: Prevention of the destruction of the acinar structure in Sjögren's syndrome salivary glands. Arthritis and Rheumatism 43: 1756–1767.CrossRef
22.
Zurück zum Zitat Song, J., C. Wu, X. Zhang, and L.M. Sorokin. 2013. In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1β-induced peritonitis. The Journal of Immunology 190: 401–410.CrossRef Song, J., C. Wu, X. Zhang, and L.M. Sorokin. 2013. In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1β-induced peritonitis. The Journal of Immunology 190: 401–410.CrossRef
23.
Zurück zum Zitat Munakata, S., Y. Tashiro, C. Nishida, A. Sato, H. Komiyama, H. Shimazu, D. Dhahri, Y. Salama, S. Eiamboonsert, K. Takeda, H. Yagita, Y. Tsuda, Y. Okada, H. Nakauchi, K. Sakamoto, B. Heissig, and K. Hattori. 2015. Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells. Gastroenterology 148: 565–578.CrossRef Munakata, S., Y. Tashiro, C. Nishida, A. Sato, H. Komiyama, H. Shimazu, D. Dhahri, Y. Salama, S. Eiamboonsert, K. Takeda, H. Yagita, Y. Tsuda, Y. Okada, H. Nakauchi, K. Sakamoto, B. Heissig, and K. Hattori. 2015. Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells. Gastroenterology 148: 565–578.CrossRef
24.
Zurück zum Zitat Fujibayashi, T., S. Sugai, N. Miyasaka, Y. Hayashi, and K. Tsubota. 2004. Revised Japanese criteria for Sjögren's syndrome (1999): Availability and validity. Modern Rheumatology 14: 425–434.CrossRef Fujibayashi, T., S. Sugai, N. Miyasaka, Y. Hayashi, and K. Tsubota. 2004. Revised Japanese criteria for Sjögren's syndrome (1999): Availability and validity. Modern Rheumatology 14: 425–434.CrossRef
25.
Zurück zum Zitat Shiboski, S.C., C.H. Shiboski, L.A. Criswell, A.N. Baer, S. Challacombe, H. Lanfranchi, M. Schiødt, H. Umehara, F. Vivino, Y. Zhao, Y. Dong, D. Greenspan, A.M. Heidenreich, P. Helin, B. Kirkham, K. Kitagawa, G. Larkin, M. Li, T. Lietman, J. Lindegaard, N. McNamara, K. Sack, P. Shirlaw, S. Sugai, C. Vollenweider, J. Whitcher, A. Wu, S. Zhang, W. Zhang, J.S. Greenspan, and T.E. Daniels for the Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups. 2012. American College of Rheumatology classification criteria for Sjögren's syndrome: A data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care and Research 64: 475–487.CrossRef Shiboski, S.C., C.H. Shiboski, L.A. Criswell, A.N. Baer, S. Challacombe, H. Lanfranchi, M. Schiødt, H. Umehara, F. Vivino, Y. Zhao, Y. Dong, D. Greenspan, A.M. Heidenreich, P. Helin, B. Kirkham, K. Kitagawa, G. Larkin, M. Li, T. Lietman, J. Lindegaard, N. McNamara, K. Sack, P. Shirlaw, S. Sugai, C. Vollenweider, J. Whitcher, A. Wu, S. Zhang, W. Zhang, J.S. Greenspan, and T.E. Daniels for the Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups. 2012. American College of Rheumatology classification criteria for Sjögren's syndrome: A data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care and Research 64: 475–487.CrossRef
26.
Zurück zum Zitat Azuma, M., T. Tamatani, Y. Kasai, and M. Sato. 1993. Immortalization of normal human salivary gland cells with duct-, myoepithelial-, acinar-, or squamous phenotype by transfection with SV40 ori- mutant deoxyribonucleic acid. Laboratory Investigation 69: 24–42.PubMed Azuma, M., T. Tamatani, Y. Kasai, and M. Sato. 1993. Immortalization of normal human salivary gland cells with duct-, myoepithelial-, acinar-, or squamous phenotype by transfection with SV40 ori- mutant deoxyribonucleic acid. Laboratory Investigation 69: 24–42.PubMed
27.
Zurück zum Zitat Bach, E.A., M. Aguet, and R.D. Schreiber. 1997. The IFNγ receptor: A paradigm for cytokine receptor signaling. Annual Review of Immunology 15: 563–591.CrossRef Bach, E.A., M. Aguet, and R.D. Schreiber. 1997. The IFNγ receptor: A paradigm for cytokine receptor signaling. Annual Review of Immunology 15: 563–591.CrossRef
28.
Zurück zum Zitat Van Lint, P., and C. Libert. 2007. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. Journal of Leukocyte Biology 82: 1375–1381.CrossRef Van Lint, P., and C. Libert. 2007. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. Journal of Leukocyte Biology 82: 1375–1381.CrossRef
29.
Zurück zum Zitat Riani, M., S. Le Jan, J. Plée, A. Durlach, R. Le Naour, G. Haegeman, P. Bernard, and F. Antonicelli. 2017. Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes. The Journal of Allergy and Clinical Immunology 139: 863–872.CrossRef Riani, M., S. Le Jan, J. Plée, A. Durlach, R. Le Naour, G. Haegeman, P. Bernard, and F. Antonicelli. 2017. Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes. The Journal of Allergy and Clinical Immunology 139: 863–872.CrossRef
30.
Zurück zum Zitat Ma, Z., H. Qin, and E.N. Benveniste. 2001. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-γ and IFN-β: Critical role of STAT-1α. The Journal of Immunology 167: 5150–5159.CrossRef Ma, Z., H. Qin, and E.N. Benveniste. 2001. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-γ and IFN-β: Critical role of STAT-1α. The Journal of Immunology 167: 5150–5159.CrossRef
31.
Zurück zum Zitat Hu, X., and L.B. Ivashkiv. 2009. Cross-regulation of signaling pathways by interferon-γ: Implications for immune responses and autoimmune diseases. Immunity 31: 539–550.CrossRef Hu, X., and L.B. Ivashkiv. 2009. Cross-regulation of signaling pathways by interferon-γ: Implications for immune responses and autoimmune diseases. Immunity 31: 539–550.CrossRef
32.
Zurück zum Zitat Proost, P., E. Schutyser, P. Menten, S. Struyf, A. Wuyts, G. Opdenakker, M. Detheux, M. Parmentier, C. Durinx, A.M. Lambeir, J. Neyts, S. Liekens, P.C. Maudgal, A. Billiau, and J. Van Damme. 2001. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98: 3554–3561.CrossRef Proost, P., E. Schutyser, P. Menten, S. Struyf, A. Wuyts, G. Opdenakker, M. Detheux, M. Parmentier, C. Durinx, A.M. Lambeir, J. Neyts, S. Liekens, P.C. Maudgal, A. Billiau, and J. Van Damme. 2001. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98: 3554–3561.CrossRef
33.
Zurück zum Zitat Mitsias, D.I., E.K. Kapsogeorgou, and H.M. Moutsopoulos. 2006. The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: Lessons from Sjogren’s syndrome (autoimmune epithelitis). Lupus 15: 255–261.CrossRef Mitsias, D.I., E.K. Kapsogeorgou, and H.M. Moutsopoulos. 2006. The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: Lessons from Sjogren’s syndrome (autoimmune epithelitis). Lupus 15: 255–261.CrossRef
Metadaten
Titel
MMP-9 Inhibition Suppresses Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells
verfasst von
Keiko Aota
Shinji Ono
Tomoko Yamanoi
Koichi Kani
Yukihiro Momota
Masayuki Azuma
Publikationsdatum
22.08.2019
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2019
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-019-01079-x

Weitere Artikel der Ausgabe 6/2019

Inflammation 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.